IL18 and systemic lupus erythematosus: IL-18 KO mice showed reduced severity in models of autoimmune diseases, e.g., arthritis, lupus, and inflammatory bowel disease (IBD) pointing to the deleterious effect of an excess of IL-18 in human diseases.